Loading
Life sciences · Interventional Study
ClinicalTrials.gov · October 5, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06058650). This is a study registration, not published results. Lead sponsor: Mayo Clinic. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 70 participants (ESTIMATED). Conditions: Breast Neoplasm. Interventions: PROCEDURE: Biopsy of Breast; OTHER: Medical Device Usage and Evaluation; RADIATION: Scintimammography; OTHER: Technetium Tc-99m Sestamibi. Primary outcome measures: Validation of timeframe , Baseline; Change in image of lesion , Baseline; Up to 6 months; Accuracy of depth estimation by difference in attenuation from opposing views , Baseline; Up to 6 months; Accuracy of depth estimation by difference in apparent lesion size , Baseline; Up to 6 months; Accuracy of depth estimation by triangulation , Baseline; Up to 6 months. Brief summary: This clinical trial tests how well molecular breast imaging (MBI) works to guide the collection of a breast biopsy in patients with a breast abnormality. Currently, a biopsy is often guided by either ultrasound or mammography in order to ensure that a sample of the correct part of the breast is taken. Sometimes a lesion or part of the lesion cannot be seen on ultrasound or mammography, and, therefore, a biopsy guided with ultrasound or mammography may not be always be accurate. Studies have shown that high resolution MBI may have potential to improve the detection of some breast tumors. This trial uses a new high-resolution MBI system that may help perform a biopsy using MBI.